this data demonstrates that agents which stimulate opiate receptors , especially the kappa receptor agonist dynorphin , increase the growth of prostatic carcinoma , and that this effect is controlled by changes at the n-terminal end of the peptide .
C0034801
opiate
C0064239
kappa receptor